Hematology Cancer Consortium - Association
Founded in 2020 and headquartered in Maharashtra, India.
2020 | Mumbai, Maharashtra (India) | Active
Hematology Cancer Consortium - Association Profile
Key Indicators
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 63.96%
- Profit Growth -64.29%
- Ebitda -74.59%
- Net Worth 11.25%
- Total Assets 45.35%
About Hematology Cancer Consortium - Association
Hematology Cancer Consortium - Association (HCCA) is a Private Not For Profit Company incorporated in India on 09 January 2020 (Five years and one month 25 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hematology Cancer Consortium - Association India is Bhavisha Sanadhya as CEO. Vikram, Palani Thyagarajan, and Niyati James serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100MH2020NPL335745
- Company No.
335745
- Company Classification
Private Not For Profit Company
- Incorporation Date
09 Jan 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Who are the key members and board of directors at Hematology Cancer Consortium - Association?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhavisha Sanadhya | CEO | 08-Dec-2021 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikram  | Director | 09-Jan-2020 | Current |
| Palani Thyagarajan | Director | 08-Dec-2021 | Current |
| Niyati James | Director | 08-Dec-2021 | Current |
Financial Performance of Hematology Cancer Consortium - Association.
Hematology Cancer Consortium - Association, for the financial year ended 2023, experienced significant growth in revenue, with a 63.96% increase. The company also saw a substantial fall in profitability, with a 64.29% decrease in profit. The company's net worth Soared by an impressive increase of 11.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hematology Cancer Consortium - Association?
Unlock access to Hematology Cancer Consortium - Association's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Advanced Medicinal Therapies Foundation (Amtf)
Vikram is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Hematology Cancer Consortium - Association?
Unlock and access historical data on people associated with Hematology Cancer Consortium - Association, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hematology Cancer Consortium - Association, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hematology Cancer Consortium - Association's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Hematology Cancer Consortium - Association
Recent activity within the organization
- Annual General Meeting
Hematology Cancer Consortium - Association last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Hematology Cancer Consortium - Association has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Bhavisha Sudarshan Sanadhya was appointed as a Ceo was appointed as a Ceo on 08 Dec 2021 & has been associated with this company since 3 years 2 months .
- Director Appointment
Palani Thyagarajan was appointed as a Director was appointed as a Director on 08 Dec 2021 & has been associated with this company since 3 years 2 months .
- Director Appointment
Niyati Sutaria James was appointed as a Director was appointed as a Director on 08 Dec 2021 & has been associated with this company since 3 years 2 months .
- Director Appointment
Vikram was appointed as a Director was appointed as a Director on 09 Jan 2020 & has been associated with this company since 5 years 1 month .
Frequently asked questions
What is the Incorporation or founding date of Hematology Cancer Consortium - Association?
Hematology Cancer Consortium - Association was incorporated on 09 Jan 2020.
What is authorized share capital and paid-up capital of Hematology Cancer Consortium - Association?
The authorized share capital of Hematology Cancer Consortium - Association is ₹ 0.00 and paid-up capital is ₹ 0.00.
Who are the current board members & directors of Hematology Cancer Consortium - Association?
Currently 4 directors are associated with Hematology Cancer Consortium - Association.
- Vikram
- Bhavisha Sudarshan Sanadhya
- Palani Thyagarajan
- Niyati Sutaria James
What is the registered address of Hematology Cancer Consortium - Association?
As per Ministry of Corporate Affairs (Mca), the registered address of Hematology Cancer Consortium - Association is Shop No. 1A Ground Floor Deep Co-Operative Housing Society Limited Jerbai Wadia Road, Parel Bhoiwada India, Mumbai, Maharashtra, 400012.
What is the corporate identification number (CIN) and company number of Hematology Cancer Consortium - Association?
The corporate identification number (CIN) of Hematology Cancer Consortium - Association is U85100MH2020NPL335745 and the company number is 335745 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Hematology Cancer Consortium - Association?
According to the financial reports for the fiscal year 2023, the revenue trend for Hematology Cancer Consortium - Association has risen by 63.96%.
What change has been observed in the net worth of Hematology Cancer Consortium - Association, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Hematology Cancer Consortium - Association has experienced an upsurge of 11.25%.
When was the last Balance Sheet of Hematology Cancer Consortium - Association filed with the ROC?
The most recent Balance Sheet for Hematology Cancer Consortium - Association was filed with the ROC on 31 Mar 2024.
People also Viewed
MS
Manju SengarDirector
Similar Companies Based on Human Health Activities
Seva Sahayog Foundation Pune, Maharashtra, India
Reliance Foundation Mumbai, Maharashtra, India
Parivar Seva Sanstha Delhi, India
Isha Institute Of Inner Sciences Coimbatore, Tamil Nadu, India
Atos Syntel Prayas Foundation Mumbai, Maharashtra, India
Kalpataru Foundation Mumbai, Maharashtra, India- Evangelical Trust Association Of North India. Delhi, India
- Bayer Foundation India Thane, Maharashtra, India